Physician profile
Ryan Moore
NPI 1356761415
$2,571.50
in general payments reported to CMS, 2019-2025
7 companies · $789 in 2025
The $789 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $123 · 2022: $20.90 · 2023: $130 · 2024: $1,509 · 2025: $789.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $1,934 · Food and Beverage: $494.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $1,934.03 |
| Food and Beverage | $493.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $2,065.49 | 2024-2025 | Acell, Durasorb Monofilament Mesh, Integra |
| Abbvie INC. | $197.78 | 2023-2024 | |
| Acelrx Pharmaceuticals, INC. | $122.66 | 2020 | |
| Mentor Worldwide LLC | $102.70 | 2024 | |
| Tela Bio, INC. | $33.14 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Musculoskeletal Transplant Foundation INC. | $28.83 | 2024 | |
| Allergan, INC. | $20.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.